Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 12 | 2019 | 1067 | 1.670 |
Why?
|
| Exercise | 13 | 2019 | 556 | 1.460 |
Why?
|
| Caloric Restriction | 4 | 2019 | 93 | 1.270 |
Why?
|
| Aging | 6 | 2017 | 894 | 1.060 |
Why?
|
| Aged | 32 | 2020 | 9561 | 1.020 |
Why?
|
| Pericardium | 2 | 2011 | 50 | 0.860 |
Why?
|
| Adipose Tissue | 4 | 2011 | 335 | 0.850 |
Why?
|
| Resistance Training | 3 | 2016 | 68 | 0.830 |
Why?
|
| Exercise Therapy | 5 | 2019 | 207 | 0.830 |
Why?
|
| Dietary Proteins | 1 | 2020 | 51 | 0.820 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 103 | 0.780 |
Why?
|
| Abdominal Fat | 3 | 2018 | 46 | 0.730 |
Why?
|
| Body Composition | 6 | 2019 | 358 | 0.720 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 1 | 2018 | 2 | 0.710 |
Why?
|
| Scavenger Receptors, Class E | 2 | 2008 | 2 | 0.710 |
Why?
|
| Life Style | 3 | 2018 | 367 | 0.700 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2018 | 38 | 0.690 |
Why?
|
| Antigens, Neoplasm | 1 | 2018 | 42 | 0.690 |
Why?
|
| Exosomes | 1 | 2018 | 36 | 0.670 |
Why?
|
| Postmenopause | 2 | 2011 | 398 | 0.660 |
Why?
|
| Female | 31 | 2020 | 18229 | 0.660 |
Why?
|
| Inflammation | 3 | 2010 | 497 | 0.650 |
Why?
|
| Adiposity | 4 | 2016 | 198 | 0.640 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2018 | 109 | 0.640 |
Why?
|
| Geriatrics | 1 | 2018 | 96 | 0.630 |
Why?
|
| Humans | 36 | 2020 | 28457 | 0.620 |
Why?
|
| Male | 29 | 2020 | 17998 | 0.600 |
Why?
|
| Vascular Diseases | 1 | 2015 | 61 | 0.560 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 297 | 0.540 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2011 | 1253 | 0.540 |
Why?
|
| Neurons | 1 | 2018 | 397 | 0.530 |
Why?
|
| Hypertension | 5 | 2017 | 948 | 0.500 |
Why?
|
| Electrocardiography | 1 | 2018 | 553 | 0.490 |
Why?
|
| Coronary Circulation | 2 | 2016 | 32 | 0.480 |
Why?
|
| Middle Aged | 17 | 2019 | 11103 | 0.470 |
Why?
|
| Physical Fitness | 3 | 2010 | 116 | 0.460 |
Why?
|
| Lipoprotein Lipase | 1 | 2011 | 14 | 0.450 |
Why?
|
| Lipoproteins, VLDL | 1 | 2011 | 27 | 0.440 |
Why?
|
| Lipase | 1 | 2011 | 28 | 0.440 |
Why?
|
| Myocardium | 2 | 2016 | 195 | 0.440 |
Why?
|
| Atherosclerosis | 3 | 2015 | 713 | 0.440 |
Why?
|
| C-Reactive Protein | 4 | 2017 | 238 | 0.420 |
Why?
|
| Aged, 80 and over | 10 | 2017 | 3692 | 0.410 |
Why?
|
| Brain | 1 | 2018 | 955 | 0.410 |
Why?
|
| Body Mass Index | 6 | 2019 | 874 | 0.410 |
Why?
|
| Exercise Tolerance | 4 | 2019 | 115 | 0.400 |
Why?
|
| Ginkgo biloba | 1 | 2010 | 19 | 0.400 |
Why?
|
| Blood Pressure | 3 | 2015 | 865 | 0.400 |
Why?
|
| Nitric Oxide | 2 | 2009 | 116 | 0.390 |
Why?
|
| Nitrites | 1 | 2009 | 22 | 0.390 |
Why?
|
| Nitrates | 1 | 2009 | 25 | 0.380 |
Why?
|
| Plant Extracts | 1 | 2010 | 60 | 0.380 |
Why?
|
| Lipoproteins, LDL | 1 | 2009 | 77 | 0.360 |
Why?
|
| Lipoproteins, HDL | 1 | 2011 | 270 | 0.360 |
Why?
|
| Aorta | 1 | 2009 | 114 | 0.360 |
Why?
|
| Comorbidity | 1 | 2009 | 539 | 0.320 |
Why?
|
| Logistic Models | 3 | 2018 | 745 | 0.310 |
Why?
|
| Heart Failure | 3 | 2018 | 611 | 0.290 |
Why?
|
| Interleukin-6 | 3 | 2012 | 228 | 0.280 |
Why?
|
| Exercise Test | 4 | 2019 | 195 | 0.270 |
Why?
|
| Sex Factors | 2 | 2017 | 650 | 0.260 |
Why?
|
| Age Factors | 3 | 2018 | 1123 | 0.220 |
Why?
|
| Gait | 3 | 2017 | 90 | 0.220 |
Why?
|
| Oxygen Consumption | 4 | 2019 | 141 | 0.210 |
Why?
|
| Cardiovascular Diseases | 3 | 2017 | 1032 | 0.210 |
Why?
|
| Polymorphism, Genetic | 2 | 2014 | 220 | 0.200 |
Why?
|
| Hand Strength | 2 | 2012 | 87 | 0.200 |
Why?
|
| Weight Loss | 2 | 2015 | 405 | 0.200 |
Why?
|
| North Carolina | 3 | 2015 | 1642 | 0.190 |
Why?
|
| Proteins | 1 | 2020 | 144 | 0.190 |
Why?
|
| Chronic Disease | 3 | 2010 | 372 | 0.190 |
Why?
|
| Intra-Abdominal Fat | 3 | 2018 | 67 | 0.190 |
Why?
|
| Mobility Limitation | 3 | 2014 | 181 | 0.180 |
Why?
|
| Sepharose | 1 | 2018 | 5 | 0.180 |
Why?
|
| Biotinylation | 1 | 2018 | 10 | 0.180 |
Why?
|
| Multivariate Analysis | 2 | 2011 | 661 | 0.180 |
Why?
|
| Risk Factors | 7 | 2017 | 3527 | 0.180 |
Why?
|
| Body Fat Distribution | 1 | 2018 | 37 | 0.180 |
Why?
|
| Research | 1 | 2018 | 74 | 0.170 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 70 | 0.170 |
Why?
|
| Protein Binding | 1 | 2018 | 192 | 0.170 |
Why?
|
| Geriatric Assessment | 4 | 2016 | 341 | 0.170 |
Why?
|
| Cell Separation | 1 | 2018 | 89 | 0.170 |
Why?
|
| Treatment Outcome | 3 | 2019 | 3027 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2018 | 1195 | 0.170 |
Why?
|
| Avitaminosis | 1 | 2017 | 3 | 0.160 |
Why?
|
| Disability Evaluation | 2 | 2019 | 223 | 0.160 |
Why?
|
| Vitamin K 1 | 1 | 2017 | 11 | 0.160 |
Why?
|
| Time Factors | 2 | 2015 | 2000 | 0.160 |
Why?
|
| Lysine | 1 | 2017 | 25 | 0.160 |
Why?
|
| Heart | 1 | 2018 | 186 | 0.160 |
Why?
|
| Gene Expression | 1 | 2018 | 331 | 0.160 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2016 | 25 | 0.150 |
Why?
|
| Dobutamine | 1 | 2016 | 50 | 0.150 |
Why?
|
| Elasticity | 1 | 2015 | 32 | 0.150 |
Why?
|
| Stroke Volume | 1 | 2018 | 291 | 0.150 |
Why?
|
| Ankle Brachial Index | 1 | 2015 | 37 | 0.140 |
Why?
|
| Waist Circumference | 1 | 2015 | 89 | 0.140 |
Why?
|
| African Continental Ancestry Group | 1 | 2017 | 382 | 0.140 |
Why?
|
| Continental Population Groups | 1 | 2017 | 233 | 0.140 |
Why?
|
| Heart Ventricles | 1 | 2016 | 114 | 0.140 |
Why?
|
| Forecasting | 1 | 2015 | 133 | 0.140 |
Why?
|
| Heart Rate | 1 | 2017 | 336 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2017 | 167 | 0.140 |
Why?
|
| Single-Blind Method | 2 | 2012 | 169 | 0.130 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2014 | 33 | 0.130 |
Why?
|
| European Continental Ancestry Group | 2 | 2017 | 1259 | 0.130 |
Why?
|
| Forced Expiratory Volume | 1 | 2014 | 112 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2015 | 462 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 532 | 0.130 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 487 | 0.130 |
Why?
|
| Triglycerides | 2 | 2011 | 216 | 0.120 |
Why?
|
| Activities of Daily Living | 2 | 2014 | 230 | 0.120 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2012 | 9 | 0.120 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2014 | 189 | 0.120 |
Why?
|
| Gene Frequency | 2 | 2014 | 274 | 0.120 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 74 | 0.110 |
Why?
|
| Perfusion | 1 | 2011 | 64 | 0.110 |
Why?
|
| DNA Primers | 1 | 2011 | 87 | 0.110 |
Why?
|
| Case-Control Studies | 2 | 2018 | 917 | 0.110 |
Why?
|
| Linear Models | 2 | 2010 | 427 | 0.110 |
Why?
|
| Base Sequence | 1 | 2011 | 229 | 0.110 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 174 | 0.110 |
Why?
|
| Hemodynamics | 1 | 2011 | 170 | 0.100 |
Why?
|
| Aortic Diseases | 1 | 2011 | 56 | 0.100 |
Why?
|
| Aorta, Thoracic | 1 | 2011 | 75 | 0.100 |
Why?
|
| Genotype | 2 | 2014 | 826 | 0.100 |
Why?
|
| Prospective Studies | 2 | 2015 | 1951 | 0.100 |
Why?
|
| Oxidative Stress | 2 | 2009 | 253 | 0.100 |
Why?
|
| Coronary Disease | 1 | 2011 | 204 | 0.100 |
Why?
|
| Plethysmography | 1 | 2009 | 9 | 0.100 |
Why?
|
| Multienzyme Complexes | 1 | 2009 | 9 | 0.100 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2009 | 10 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2015 | 1299 | 0.100 |
Why?
|
| Blood Flow Velocity | 1 | 2009 | 62 | 0.090 |
Why?
|
| Probability | 1 | 2009 | 148 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 2088 | 0.090 |
Why?
|
| Absorptiometry, Photon | 2 | 2019 | 131 | 0.090 |
Why?
|
| Double-Blind Method | 1 | 2010 | 519 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2010 | 170 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 1532 | 0.090 |
Why?
|
| Exons | 1 | 2008 | 52 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2011 | 1662 | 0.090 |
Why?
|
| Thinness | 1 | 2008 | 30 | 0.090 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 202 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 199 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2008 | 99 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 523 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2009 | 117 | 0.080 |
Why?
|
| Lipids | 1 | 2009 | 218 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 1325 | 0.080 |
Why?
|
| Incidence | 1 | 2010 | 1072 | 0.080 |
Why?
|
| Kidney | 1 | 2010 | 468 | 0.080 |
Why?
|
| Body Weight | 1 | 2008 | 297 | 0.080 |
Why?
|
| Overweight | 1 | 2008 | 256 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2016 | 2921 | 0.070 |
Why?
|
| Subcutaneous Fat, Abdominal | 2 | 2018 | 14 | 0.070 |
Why?
|
| Adult | 2 | 2011 | 8519 | 0.050 |
Why?
|
| Antihypertensive Agents | 2 | 2017 | 367 | 0.050 |
Why?
|
| Health Education | 2 | 2014 | 131 | 0.050 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 113 | 0.050 |
Why?
|
| Executive Function | 1 | 2019 | 55 | 0.050 |
Why?
|
| Fatigue | 1 | 2019 | 72 | 0.050 |
Why?
|
| Thigh | 1 | 2018 | 38 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2019 | 390 | 0.040 |
Why?
|
| Muscle Strength | 1 | 2018 | 129 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 48 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 40 | 0.040 |
Why?
|
| Myocardial Ischemia | 1 | 2017 | 84 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2019 | 483 | 0.040 |
Why?
|
| Echocardiography, Stress | 1 | 2016 | 22 | 0.040 |
Why?
|
| Coronary Stenosis | 1 | 2016 | 29 | 0.040 |
Why?
|
| Calcinosis | 1 | 2017 | 157 | 0.040 |
Why?
|
| Microcirculation | 1 | 2016 | 56 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2016 | 54 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 142 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 717 | 0.030 |
Why?
|
| Cognition | 1 | 2019 | 529 | 0.030 |
Why?
|
| Spirometry | 1 | 2014 | 33 | 0.030 |
Why?
|
| Brachial Artery | 1 | 2014 | 65 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 245 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 410 | 0.030 |
Why?
|
| Stroke | 1 | 2017 | 552 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 66 | 0.030 |
Why?
|
| Dinoprost | 1 | 2009 | 11 | 0.020 |
Why?
|
| Nitrogen Oxides | 1 | 2009 | 5 | 0.020 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2009 | 25 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 46 | 0.020 |
Why?
|
| Antioxidants | 1 | 2009 | 113 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2009 | 165 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 472 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 452 | 0.020 |
Why?
|
| United States | 1 | 2015 | 3609 | 0.020 |
Why?
|
| Health Status | 1 | 2008 | 378 | 0.020 |
Why?
|
| Animals | 1 | 2010 | 7456 | 0.010 |
Why?
|